News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History
Patricia LoRusso has received the AACI 2023 Distinguished Scientist Award – Yale Cancer Center
Photo of Patricia LoRusso taken from Yale Cancer Center
30/10/2023 07:19

Patricia LoRusso has received the AACI 2023 Distinguished Scientist Award – Yale Cancer Center

Yale Cancer Center recently posted on LinkedIn,

“Patricia LoRusso has received the AACI (Association of American Cancer Institutes) 2023 Distinguished Scientist Award. The AACI Distinguished Scientist Award was created in 2002 to recognize a major contributor to the field of cancer research. Upon accepting the award, Dr. LoRusso presented a heartwarming and gripping personal account of her clinical research career at the AACI annual meeting. Dr. LoRusso was integrally involved in the early development of more than two dozen anti-cancer agents that are now FDA-approved and has pioneered trial designs that have led to more efficient clinical drug development strategies.
Congratulations, Dr. LoRusso!”

Source: Yale Cancer Center/LinkedIn

AACI cancer OncoDaily Oncology Patricia LoRusso Yale Cancer Center
Blog
16:27 30/11/23
David Lubarsky: 4 Ms
Drugs
16:23 30/11/23
Mariana Brandao: My comment on the ARTEMIDE-01 phase I trial testing a new bispecific anti-PD-1/anti-TIGIT antibody called Rilvegostomig
Blog
16:18 30/11/23
Do you want to be part of the first-ever national cancer innovation accelerator initiative with public support from The White House? - CancerX Moonshot
Opinion
16:11 30/11/23
Gavin Preston: If thinking of going into medicine to get rich, forget it
Blog
16:04 30/11/23
Two charities will co-fund a major £5.5 million research programme called Stratified Medicine Paediatrics 2 - The Institute of Cancer Research
Blog
15:58 30/11/23
Aju Mathew: Rising numbers of hepatocellular carcinoma in India
Blog
15:51 30/11/23
Bente Mikkelsen: This is the latest edition of the IARC handbook series and covers the topic of oral cancer prevention
Blog
15:43 30/11/23
Rebekka K. Schneider: Our research will be supported by an European Research Council (ERC) consolidator grant
Blog
15:39 30/11/23
Otilia Ciobanu: Review on the potential of targeting the subventricular zone for improved outcomes in high-grade gliomas
Blog
15:33 30/11/23
Andre Lopes Carvalho: I had the incredible opportunity to celebrate the 20th anniversary of ZORA
Drugs
15:29 30/11/23
David Steensma: Randomized STIMULUS-MDS1 trial didn't meet endpoint
Blog
15:25 30/11/23
Monica M. Bertagnolli: One of my priorities is ensuring all people are represented in clinical trials
Insight
Positive
Societies
Career